Fusion Pharm (FSPM) Stock Price
Fusion Pharm Price
Revenue at Fusion Pharm has contracted by 12.1% per year over the past 18 years to 808,400.00 USD. Fusion Pharm's net margin stands at 32.8%, up from -28.5% several years earlier.
Fusion Pharm stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Fusion Pharm business model & stock analysis
Frequently asked questions about Fusion Pharm
The business model of Fusion Pharm Inc is centered around providing innovative vertical farming solutions. The company designs and manufactures state-of-the-art cultivation systems known as PharmPods, which are fully equipped shipping containers for growing produce in a controlled environment. Fusion Pharm's business model aims to revolutionize the agriculture industry by offering efficient and sustainable farming solutions that optimize space, resources, and yields. With its cutting-edge technology and expertise in vertical farming, Fusion Pharm Inc aims to meet the increasing demand for locally grown, pesticide-free, and high-quality food products.
Fusion Pharm Inc is primarily active in the industries of horticulture, agriculture, and cannabis cultivation.
The main competitors of Fusion Pharm Inc in the market include companies like GrowLife Inc, Terra Tech Corp, and MedMen Enterprises Inc.
Fusion Pharm Inc, now known as Pharmagreen Biotech Inc, is a Canadian cannabis company. Founded in 2011, Fusion Pharm initially focused on providing vertical farming solutions for growing medicinal herbs and leafy greens. However, in 2018, the company shifted its focus to the cannabis industry and rebranded as Pharmagreen Biotech. With a mission to revolutionize the cannabis cultivation industry, Pharmagreen specializes in the development and licensing of tissue culture plantlets. Through their proprietary technology, the company aims to produce genetically superior, disease-free plantlets while reducing cultivation costs and enhancing overall yields. Pharmagreen Biotech Inc continues to innovate and contribute to the advancement of the cannabis sector.
Fusion Pharm Inc has achieved several significant milestones. The company successfully developed and patented its proprietary PharmPods™ technology, which revolutionizes the cultivation of organic produce and medicinal plants. Fusion Pharm Inc also established strategic partnerships with leading horticultural and agricultural companies, enabling widespread adoption of their innovative growing systems. Additionally, the company expanded its operations internationally, reaching markets in Europe, Asia, and the Americas. Fusion Pharm Inc's dedication to sustainable and efficient cultivation methods has garnered accolades and recognition within the industry. These achievements highlight Fusion Pharm Inc's commitment to advancing the field of indoor agriculture.
Fusion Pharm Inc is primarily present in the United States.
Fusion Pharm Inc represents values of innovation, sustainability, and growth in the agricultural industry. With a focus on providing cutting-edge vertical farming technologies, the company aims to revolutionize traditional farming practices. Fusion Pharm Inc believes in the importance of environmentally friendly solutions that maximize crop production while minimizing resource usage. By fostering partnerships and collaborations, Fusion Pharm Inc strives to create a global network of sustainable farming systems. With a commitment to advancing the future of agriculture, Fusion Pharm Inc is dedicated to providing efficient and profitable solutions for farmers around the world.
Converted at the current exchange rate, the Fusion Pharm share trades at 0.00 EUR (0.00 USD).
Fusion Pharm Inc is a company that operates in various business areas, including the manufacturing of greenhouses, production of primarily organic supplements, and offering consulting services for agriculture and construction.
The revenue cannot currently be calculated for Fusion Pharm.
The profit cannot currently be calculated for Fusion Pharm.
The P/E ratio cannot be calculated for Fusion Pharm at the moment.
The P/S cannot be calculated for Fusion Pharm currently.
The Eulerpool Quality Score for Fusion Pharm is 3/10.
The ISIN of Fusion Pharm is US36113H1005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Fusion Pharm is A1H9CD. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Fusion Pharm is FSPM. The ticker symbol is used to trade Fusion Pharm shares on the stock exchange.
Fusion Pharm stock
Fusion Pharm Peer Group
Fusion Pharm Ticker
Fusion Pharm FIGI
All fundamentals and in-depth analysis of Fusion Pharm
Our stock analysis for Fusion Pharm stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fusion Pharm. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.